November 9, 2015 M&A, Partnerships

GE Healthcare Acquires Leading Healthcare Advisory Firm, The Camden Group, to enable Healthcare Organizations to Navigate Industry Transformation

BARRINGTON, Ill., November 9, 2015 — GE Healthcare (NYSE: GE) announced today it is expanding its U.S. healthcare consulting business with the acquisition of The Camden Group, one of the nation’s leading population health & strategic advisory firms. GE Healthcare Camden Group will act as the U.S. business unit of GE Healthcare’s global advisory firm,... Read more

November 9, 2015 Bio/Pharma/CRO Life Science Tools

It Takes Two: GE Healthcare and SHINE team up to solve longstanding radiopharmaceutical supply concerns in medical imaging

CHALFONT ST. GILES, UK – 9 November 2015 – Technetium-99m (Tc‑99m) is used in more than 40 million medical imaging procedures each year, primarily stress tests to assess heart disease, and bone scans to determine the stage of cancer progression. This essential medical isotope is generated in pharmacies and hospitals from another isotope—molybdenum-99 (Mo-99).  Despite... Read more

October 5, 2015 Acad, Gov/Utilities

Leakwise Oil-on-Water Demo Video

Oct 5, 2015 – Boulder, CO – GE Analytical Instruments invites you to view the Leakwise Oil-on-Water Monitoring System demonstration video. In addition to an overview of the new SLC-220 Controller, this video reviews the capablities of various types of Leakwise Sensors for multiple applications and needs, as well as types of communication, and options that are available... Read more

September 24, 2015 Acad, Gov/Utilities Clinical Research/Diagn.

Precise Diagnosis for Precision Lung Cancer Drug: GE Healthcare’s Clarient Diagnostics Offering FDA approved PD-L1 companion diagnostic for Merck’s Keytruda®

California, USA – 2 October 2015 –  Clarient Diagnostic Services, Inc. a division of GE Healthcare (NYSE:GE) announced it will be offering the FDA approved PD-L1 companion diagnostic which will help identify patients most likely to benefit from Merck’s newly-approved lung cancer drug, Keytruda.   http://www.genewsroom.com/press-releases/precise-diagnosis-precision-lung-cancer-drug-ge-healthcare%E2%80%99s-clarient-diagnostics Read more

September 23, 2015 Uncategorized

GE HEALTHCARE ANNOUNCES $300 MILLION COMMITMENT TO SUPPORT EMERGING MARKET HEALTH

New York City, NY – September 23, 2015 – GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop high-value, low-cost technologies and healthcare delivery solutions across multiple care settings. http://www.genewsroom.com/press-releases/ge-healthcare-announces-300-million-commitment-support-emerging-market-health-281784 Read more

September 10, 2015 Uncategorized

GE Healthcare commends DEA decision that will make DaTscan™ (Ioflupane I 123 Injection) more available to patients who may have Parkinsonism

GE Healthcare (NYSE:GE) is pleased to announce that the US Drug Enforcement Administration (DEA) has removed the compound ioflupane I 123 from the schedules of the Controlled Substance Act, which has resulted in the descheduling of DaTscan™ (Ioflupane I 123 Injection). http://www.genewsroom.com/press-releases/ge-healthcare-commends-dea-decision-will-make-datscan%E2%84%A2-ioflupane-i-123-injection-more Read more

September 7, 2015 M&A, Partnerships

Fujifilm Kyowa Kirin Biologics selects GE’s innovative MabSelect SuRe LX media for biomanufacturing process

Tokyo, Japan and Chalfont St Giles, UK – 7 September 2015 –  GE Healthcare today announced that Fujifilm Kyowa Kirin Biologics has selected GE Healthcare’s innovative MabSelect SuRe™ LX high-affinity chromatography media for the manufacture of monoclonal antibodies. http://www.genewsroom.com/press-releases/fujifilm-kyowa-kirin-biologics-selects-ge%E2%80%99s-innovative-mabselect-sure-lx-media Read more

August 25, 2015 Acad, Gov/Utilities M&A, Partnerships Microscopy

Temple University Health System and GE Healthcare Sign Innovative Value-Based Radiology Services Collaboration Agreement

PHILADELPHIA, PA – August 25, 2015 –  Academic medical centers across the U.S. are experiencing increasing pressure to enhance value – deliver higher quality at lower cost – as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics.  Initiatives to promote value typically involve reimbursement arrangements between health insurers... Read more